A reduction in the activity of CAT in serum was found in anti-GBM-GN, and a significant decrease in the activity of GPX was observed in patients with systemic lupus erythematosus (SLE) [19,26]. The gene discussed is CAT; the disease is systemic lupus erythematosus.